Product
TAPCells
1 clinical trial
2 indications
Indication
Malignant Melanoma of SkinIndication
MelanomaClinical trial
Phase I/II Trial In Stage III/IV Malignant Melanoma Using Autologous Dendritic Cells Loaded With Tumor Cell Lysates And Low Doses Of ProleukinStatus: Completed, Estimated PCD: 2004-10-09